相似文献
1
Nanomicelles: an emerging platform for drug delivery to the eye.
Ther Deliv. 2013 Jan;4(1):1-3. doi: 10.4155/tde.12.122.
2
Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
Expert Opin Drug Deliv. 2019 Apr;16(4):397-413. doi: 10.1080/17425247.2019.1597848. Epub 2019 Apr 8.
3
Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
Ther Deliv. 2018 Feb;9(2):137-153. doi: 10.4155/tde-2017-0088.
4
Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Expert Opin Drug Deliv. 2018 Jul;15(7):687-701. doi: 10.1080/17425247.2018.1496080. Epub 2018 Jul 16.
5
Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone.
Carbohydr Polym. 2020 Jan 1;227:115356. doi: 10.1016/j.carbpol.2019.115356. Epub 2019 Sep 20.
6
Drug delivery to the posterior segment of the eye.
Eur J Ophthalmol. 2011;21 Suppl 6:S20-6. doi: 10.5301/EJO.2010.6051.
7
Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases.
Biol Pharm Bull. 2020;43(4):596-607. doi: 10.1248/bpb.b19-00858.
8
In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye.
Curr Eye Res. 2010 Dec;35(12):1081-9. doi: 10.3109/02713683.2010.508867. Epub 2010 Oct 20.
9
Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy.
J Nanobiotechnology. 2021 Jan 7;19(1):10. doi: 10.1186/s12951-020-00745-9.
10
Nano-ophthalmology: Applications and considerations.
Nanomedicine. 2017 May;13(4):1459-1472. doi: 10.1016/j.nano.2017.02.007. Epub 2017 Feb 21.
引用本文的文献
1
Drug delivery strategies to improve the treatment of corneal disorders.
Heliyon. 2025 Jan 10;11(2):e41881. doi: 10.1016/j.heliyon.2025.e41881. eCollection 2025 Jan 30.
2
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders.
Pharmaceuticals (Basel). 2025 Jan 13;18(1):87. doi: 10.3390/ph18010087.
3
Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma.
Sci Rep. 2024 Nov 7;14(1):27051. doi: 10.1038/s41598-024-78244-2.
4
A comprehensive review on alpha-lipoic acid delivery by nanoparticles.
Bioimpacts. 2024;14(6):30136. doi: 10.34172/bi.2024.30136. Epub 2024 Feb 26.
5
Seeing the Future: A Review of Ocular Therapy.
Bioengineering (Basel). 2024 Feb 13;11(2):179. doi: 10.3390/bioengineering11020179.
6
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment.
Pharmaceutics. 2023 Jul 1;15(7):1862. doi: 10.3390/pharmaceutics15071862.
7
Machine Learning for Property Prediction and Optimization of Polymeric Nanocomposites: A State-of-the-Art.
Int J Mol Sci. 2022 Sep 14;23(18):10712. doi: 10.3390/ijms231810712.
8
Nanomicelles: Types, properties and applications in drug delivery.
IET Nanobiotechnol. 2021 Feb;15(1):19-27. doi: 10.1049/nbt2.12018. Epub 2021 Feb 2.
9
Inulin-Based Polymeric Micelles Functionalized with Ocular Permeation Enhancers: Improvement of Dexamethasone Permeation/Penetration through Bovine Corneas.
Pharmaceutics. 2021 Sep 9;13(9):1431. doi: 10.3390/pharmaceutics13091431.
10
Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.
J Mol Biol Ther. 2019;1:44-55.
本文引用的文献
1
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.
Recent Pat Biomed Eng. 2012 Apr 1;5(1):83-101. doi: 10.2174/1874764711205010083.
2
Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
Recent Pat Nanomed. 2012;2(2):82-95. doi: 10.2174/1877912311202020082.
3
Drug delivery to the posterior segment of the eye.
Eur J Ophthalmol. 2011;21 Suppl 6:S20-6. doi: 10.5301/EJO.2010.6051.
4
Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.
Recent Pat Antiinfect Drug Discov. 2012 Apr;7(1):8-18. doi: 10.2174/157489112799829765.
5
Ocular drug delivery.
AAPS J. 2010 Sep;12(3):348-60. doi: 10.1208/s12248-010-9183-3. Epub 2010 May 1.
6
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
Nanomedicine (Lond). 2010 Apr;5(3):485-505. doi: 10.2217/nnm.10.10.
7
Recent perspectives in ocular drug delivery.
Pharm Res. 2009 May;26(5):1197-216. doi: 10.1007/s11095-008-9694-0. Epub 2008 Aug 29.
8
Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Pharmazie. 2008 Mar;63(3):171-9.
9
Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Drug Discov Today. 2008 Feb;13(3-4):135-43. doi: 10.1016/j.drudis.2007.11.002. Epub 2008 Jan 8.
10
Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.
Drugs Aging. 2007;24(7):581-602. doi: 10.2165/00002512-200724070-00006.
Zotero 插件